Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...
Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention.
The Rajiv Gandhi Centre for Biotechnology becomes a national Next-Generation Sequencing hub, aiming to combat acute febrile illnesses through advanced metagenomic surveillance. A collaborative project ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
This eBook explores next-generation sequencing (NGS) methods and their applications in neurological and cancer research, with key content from BioTechniques’ digital hub and Taylor & Francis journals, ...
The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
NCI-MATCH next-generation sequencing assay for detecting genetic mutations in tumors is sensitive, specific, and reproducible, reports The Journal of Molecular Diagnostics One of the most promising ...
Thiruvananthapuram: Rajiv Gandhi Centre for Biotechnology (RGCB) was selected as one of the four next-generation sequencing (NGS) hubs for Metagenomic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback